Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1964 Jun;43(6):1116–1124. doi: 10.1172/JCI104996

Effects of Dopamine in Man: Augmentation of Sodium Excretion, Glomerular Filtration Rate, and Renal Plasma Flow*

Robert H McDonald Jr 1,2,†, Leon I Goldberg 1,2,‡, John L McNay 1,2,§, Elbert P Tuttle Jr 1,2,ǁ
PMCID: PMC289593  PMID: 14171789

Full text

PDF
1116

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLWOOD M. J., COBBOLD A. F., GINSBURG J. Peripheral vascular effects of noradrenaline, isopropylnoradrenaline and dopamine. Br Med Bull. 1963 May;19:132–136. doi: 10.1093/oxfordjournals.bmb.a070031. [DOI] [PubMed] [Google Scholar]
  2. BLASCHKO H. The development of current concepts of catecholamine formation. Pharmacol Rev. 1959 Jun;11(2 Pt 2):307–316. [PubMed] [Google Scholar]
  3. BOGDONOFF M. D., LINHART J. W., KLEIN R. J., ESTES E. H., Jr The specific structure of compounds effecting fat mobilization in man. J Clin Invest. 1961 Nov;40:1993–1996. doi: 10.1172/JCI104425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BURN J. H., RAND M. J. The depressor action of dopamine and adrenaline. Br J Pharmacol Chemother. 1958 Dec;13(4):471–479. doi: 10.1111/j.1476-5381.1958.tb00240.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barger G., Dale H. H. Chemical structure and sympathomimetic action of amines. J Physiol. 1910 Oct 11;41(1-2):19–59. doi: 10.1113/jphysiol.1910.sp001392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bradley S. E., Chasis H., Goldring W., Smith H. W. HEMODYNAMIC ALTERATIONS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS DURING THE PYROGENIC REACTION. J Clin Invest. 1945 Sep;24(5):749–758. doi: 10.1172/JCI101660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CARLSSON A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev. 1959 Jun;11(2 Pt 2):490–493. [PubMed] [Google Scholar]
  8. DAVIES D. F., SHOCK N. W. The variability of measurement of insulin and diodrast tests of kidney function. J Clin Invest. 1950 May;29(5):491–495. doi: 10.1172/JCI102285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DAVIS J. O., SHOCK N. W. The effect of theophylline ethylene diamine on renal function in control subjects and in patients with congestive heart failure. J Clin Invest. 1949 Nov;28(6 Pt 2):1459–1468. doi: 10.1172/JCI102211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. DODGE H. T., LORD J. D., SANDLER H. Cardiovascular effects of isoproterenol in normal subjects and subjects with congestive heart failure. Am Heart J. 1960 Jul;60:94–105. doi: 10.1016/0002-8703(60)90063-6. [DOI] [PubMed] [Google Scholar]
  11. FRYE R. L., KAHLER R. L., BRAUNWALD E. The ineffectiveness of an inotropic agent, mephentermine (Wyamine), in the treatment of congestive heart failure. Am Heart J. 1961 Sep;62:301–303. doi: 10.1016/0002-8703(61)90395-7. [DOI] [PubMed] [Google Scholar]
  12. GOLDBERG L. I., MCDONALD R. H., Jr, ZIMMERMAN A. M. SODIUM DIURESIS PRODUCED BY DOPAMINE IN PATIENTS WITH CONGESTIVE HEART FAILURE. N Engl J Med. 1963 Nov 14;269:1060–1064. doi: 10.1056/NEJM196311142692003. [DOI] [PubMed] [Google Scholar]
  13. GORNEL D. L., LANCESTREMERE R. G., PAPPER S., LOWENSTEIN L. M. Acute changes in renal excretion of water and solute in patients with Laennec's cirrhosis, induced by the administration of the pressor amine, metaraminol. J Clin Invest. 1962 Mar;41:594–603. doi: 10.1172/JCI104514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. HOLTZ P. Role of L-DOPA decarboxylase in the biosynthesis of catecholamines in nervous tissue and the adrenal medulla. Pharmacol Rev. 1959 Jun;11(2 Pt 2):317–329. [PubMed] [Google Scholar]
  15. HORWITZ D., FOX SM 3. D., GOLDBERG L. I. Effects of Dopamine in man. Circ Res. 1962 Feb;10:237–243. doi: 10.1161/01.res.10.2.237. [DOI] [PubMed] [Google Scholar]
  16. HORWITZ D., GOLDBERG L. I., SJOERDSMA A. Increased blood pressure responses to dopamine and norepinephrine produced by monoamine oxidase inhibitors in man. J Lab Clin Med. 1960 Nov;56:747–753. [PubMed] [Google Scholar]
  17. LI T. H., SHIMOSATO S., ETSTEN B. Hemodynamics of mephentermine in man. N Engl J Med. 1962 Jul 26;267:180–184. doi: 10.1056/NEJM196207262670404. [DOI] [PubMed] [Google Scholar]
  18. LIVESAY W. R., MOYER J. H., CHAPMAN D. W. The cardiovascular and renal hemodynamic effects of aramine. Am Heart J. 1954 May;47(5):745–756. doi: 10.1016/0002-8703(54)90195-7. [DOI] [PubMed] [Google Scholar]
  19. MAXWELL M. H., MORALES P., CROWDER C. H., Jr Effect of therapeutic doses of ephedrine on renal clearances in normal man. Proc Soc Exp Biol Med. 1951 Jul;77(3):539–542. doi: 10.3181/00379727-77-18841. [DOI] [PubMed] [Google Scholar]
  20. MOYER J. H., HANDLEY C. A., HUGGINS R. A. Some pharmacodynamic effects of 1-hydrazinophthalazine (C-5968) with particular reference to renal function and cardiovascular response. J Pharmacol Exp Ther. 1951 Dec;103(4):368–376. [PubMed] [Google Scholar]
  21. NICKEL J. F., SMYTHE C. M., PAPPER E. M., BRADLEY S. E. A study of the mode of action of the adrenal medullary hormones on sodium, potassium and water excretion in man. J Clin Invest. 1954 Dec;33(12):1687–1699. doi: 10.1172/JCI103049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. PULLMAN T. N., McCLURE W. W. The effect of l-nor-adrenaline on electrolyte excretion in normal man. J Lab Clin Med. 1952 May;39(5):711–719. [PubMed] [Google Scholar]
  23. PULLMAN T. N., McCLURE W. W. The response of the renal circulation in man to constant-speed infusions of l-norepinephrine. Circulation. 1954 Apr;9(4):600–605. doi: 10.1161/01.cir.9.4.600. [DOI] [PubMed] [Google Scholar]
  24. REUBI F. C. Renal hyperemia induced in man by a new phthalazine derivative. Proc Soc Exp Biol Med. 1950 Jan;73(1):102–102. doi: 10.3181/00379727-73-17591. [DOI] [PubMed] [Google Scholar]
  25. SANDLER H., DODGE H. T., MURDAUGH H. V., Jr Effects of isoproterenol on cardiac output and renal function in congestive heart failure. Am Heart J. 1961 Nov;62:643–651. doi: 10.1016/0002-8703(61)90372-6. [DOI] [PubMed] [Google Scholar]
  26. Smith H. W., Finkelstein N., Aliminosa L., Crawford B., Graber M. THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. J Clin Invest. 1945 May;24(3):388–404. doi: 10.1172/JCI101618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. WILKINSON E. L., BACKMAN H., HECHT H. H. Cardiovascular and renal adjustments to a hypotensive agent (l'hydrazinophthalazine: Ciba BA-5968: apresoline). J Clin Invest. 1952 Oct;31(10):872–879. doi: 10.1172/JCI102674. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES